Perspective on How the FDA Should Review Diagnostic Radiopharmaceuticals

J Nucl Med. 2018 Jun;59(6):865-867. doi: 10.2967/jnumed.117.204446. Epub 2018 Mar 30.
No abstract available

Publication types

  • Comment

MeSH terms

  • Drug Approval*
  • Radiopharmaceuticals*
  • United States Food and Drug Administration

Substances

  • Radiopharmaceuticals